News

Eywa Pharma raises $30 million

eywa

Singapore-based generic pharmaceutical firm Eywa Pharma Ptv Ltd has secured $30 million from a group of investors including Eight Roads Ventures India, the proprietary investment arm of FIL, Fidelity International Ltd, and the US-based F-Prime Capital eywaPartners.

Envestor Ventures Ltd, together with its affiliates (part of the Shriram Group), also participated in this funding round. Other terms of the deal were not disclosed.

Incorporated in 2015, Eywa is engaged in research and development, manufacture, marketing, sale and distribution of generic finished dosage formulations and provides affordable generic pharmaceuticals across the world.

 

Don't be shellfish...Share on FacebookShare on Google+Share on LinkedInShare on StumbleUponPin on PinterestTweet about this on Twitter
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top